Page 174«..1020..173174175176..180190..»

Contrast Media Market is Expected to Reach $6.1 billion … – InvestorsObserver

Posted: Published on May 6th, 2023

Contrast Media Market is Expected to Reach $6.1 billion | MarketsandMarkets. Chicago, May 03, 2023 (GLOBE NEWSWIRE) -- The contrast media industry is expected to experience growth in the near future due to the increasing demand for diagnostic imaging and the rising prevalence of chronic diseases. Contrast media are substances that enhance the visibility of internal organs, blood vessels, and tissues during imaging procedures, such as X-rays, CT scans, and MRI scans. Continue reading →

Posted in Molecular Cardiology | Comments Off on Contrast Media Market is Expected to Reach $6.1 billion … – InvestorsObserver

Global In-Vitro Diagnostics Market to Reach USD 180.62 Bn by 2032, Fueled by Growing Prevalence of Chronic – EIN News

Posted: Published on May 6th, 2023

The global in-vitro diagnostics market size is expected to account for USD 180.62 Billion in 2032 and register a robust revenue CAGR of 4.6%. In-vitro diagnostics (IVDs) have gained significant importance in the medical device industry. The rising prevalence of chronic diseases like diabetes, cardiovascular diseases, and genetic disorders has led to an increased demand for IVD products and services in medical centers. Continue reading →

Posted in Molecular Cardiology | Comments Off on Global In-Vitro Diagnostics Market to Reach USD 180.62 Bn by 2032, Fueled by Growing Prevalence of Chronic – EIN News

Nuclear Medicine Or Radiopharmaceuticals Market To Grow At A 7.6% CAGR By 2028: Size, Share, Growth And Trends – openPR

Posted: Published on May 6th, 2023

Market Overview:The Nuclear Medicine or Radiopharmaceuticals Market was valued at USD 5700 million in 2021 and is expected to reach USD 9520 million by the year 2028, at a CAGR of 7.6%. The practice of nuclear medicine involves the use of radioactive materials in diagnostic or treatments, primarily for the treatment of various cancers. Small quantities of radioactive chemicals known as radiotracers are used in nuclear medicine throughout the imaging or diagnostic procedure. Continue reading →

Posted in Molecular Cardiology | Comments Off on Nuclear Medicine Or Radiopharmaceuticals Market To Grow At A 7.6% CAGR By 2028: Size, Share, Growth And Trends – openPR

How does stress from everyday life impact heart health? – UC Davis Health

Posted: Published on May 6th, 2023

(SACRAMENTO) A team of UC Davis Health scientists is establishing a new research center to study the impact of stress from everyday life on heart health in underserved communities. The American Heart Association is funding the new UC Davis PRECISE Center (Psychosocial stRessors and Exposomics on CV health In underServed multiEthnic populations in Northern, California). Its part of a $13 million initiative to study the impact of chronic stress on cardiovascular disease and health Continue reading →

Posted in Cardiovascular Pharmacology | Comments Off on How does stress from everyday life impact heart health? – UC Davis Health

Meet the School of Medicine’s 2023 Distinguished Professors – Duke University School of Medicine

Posted: Published on May 6th, 2023

This spring, 27 faculty members in the Duke University School of Medicine have been awarded distinguished professorships. The new distinguished professors were honored at the annual distinguished professorship event on May 4 Continue reading →

Posted in Cardiovascular Pharmacology | Comments Off on Meet the School of Medicine’s 2023 Distinguished Professors – Duke University School of Medicine

Heart Rhythm Society HRS2023 Annual Meeting Program Preview – Diagnostic and Interventional Cardiology

Posted: Published on May 6th, 2023

May 2, 2023 The Heart Rhythm Society (HRS) is making final preparations for its Annual Heart Rhythm Meeting, HRS2023,which continues to bring together thelargest gathering of heart rhythm professionalsfrom around the world. Attendees will join colleaguesin person at the Ernest N Continue reading →

Posted in Cardiovascular Pharmacology | Comments Off on Heart Rhythm Society HRS2023 Annual Meeting Program Preview – Diagnostic and Interventional Cardiology

Redox-driven cardioprotective effects of sodium-glucose co … – Cardiovascular Diabetology

Posted: Published on May 6th, 2023

Diabetes Atlas. https://diabetesatlas.org/. Accessed 22 September 2022. Continue reading →

Posted in Cardiovascular Pharmacology | Comments Off on Redox-driven cardioprotective effects of sodium-glucose co … – Cardiovascular Diabetology

Maron Will Co-Direct Institute for Health Computing – UMB News

Posted: Published on May 6th, 2023

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced on May 1 that Bradley A. Maron, MD, associate professor of medicine at Brigham & Womens Hospital (BWH) and Harvard Medical School (HMS) and co-director of the Pulmonary Vascular Disease Center at the VA Boston Healthcare System, has been appointed co-director of the new University of Maryland Institute for Health Computing (UM-IHC), director of scientific operations for the UM-IHC, as well as senior associate dean for precision medicine at UMSOM, effective May 1, 2023 Continue reading →

Posted in Cardiovascular Pharmacology | Comments Off on Maron Will Co-Direct Institute for Health Computing – UMB News

Inhibikase takes steps ahead of study of IkT-148009 for… – Parkinson’s News Today

Posted: Published on May 6th, 2023

A once-daily 200 mg dose of IkT-148009, Inhibikase Therapeutics investigational therapy for Parkinsons disease, reached steady levels in the body after four days without causing any serious side effects in healthy volunteers. The company plans to include this dose in its ongoing Phase 2 study (NCT05424276) in people with Parkinsons a trial thats part of its so-called 201 program and has shared the new data with the U.S Continue reading →

Posted in Parkinson's Treatment | Comments Off on Inhibikase takes steps ahead of study of IkT-148009 for… – Parkinson’s News Today

Crowdsourcing can help researchers assess efficacy of Parkinson’s … – New York University

Posted: Published on May 6th, 2023

Untrained listeners who are crowdsourced to assess voice treatment for people with Parkinsons can reach conclusions that agree with reliable measurement tools, finds a team of speech-language pathology researchers. Studies of speech and voice treatment methods for individuals with Parkinsons Disease typically evaluate progress using fine-grained acoustic measures or highly trained listeners perceptual ratings, says lead author Tara McAllister, NYU Steinhardt Associate Professor. However, this approach leaves some uncertainty about the real-world impact of these changes, since it is not always clear they would be apparent to untrained listeners that patients interact with in their daily life Continue reading →

Posted in Parkinson's Treatment | Comments Off on Crowdsourcing can help researchers assess efficacy of Parkinson’s … – New York University

Page 174«..1020..173174175176..180190..»